𝗝𝗶𝗻𝗸𝗼 𝗦𝗸𝗶𝗹𝗹𝘀 𝗮𝗿𝗲 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗶𝗻 𝗢𝗽𝗲𝗻𝗔𝗜 𝗽𝗹𝘂𝗴𝗶𝗻𝘀! A new way for AI agents to run Jinkō’s modeling workflows directly, without requiring each step to be performed manually. This connects Jinkō’s modeling capabilities with AI agents, with a number of Jinkō Skills, now available through OpenAI plugins. And throughout the process, 𝘁𝗿𝗮𝗰𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝘁𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝗰𝘆 𝗮𝗿𝗲 𝗽𝗿𝗲𝘀𝗲𝗿𝘃𝗲𝗱: every step remains auditable, just as when the same procedure is run manually in Jinkō. Explore them now: In OpenAI (chatGPT), go to plugins, and search for Jinkō. Install Jinkō - Run in-silico clinical trials Harness the power of agentic modeling with Jinkō! Discover more on the latest Jinkō releases notes: https://lnkd.in/e_fc4gP5 #JinkoSkills #AgenticAI #InSilicoComputationalModeling
Nova In Silico
Développement de logiciels
Lyon, Rhône 5 402 abonnés
Nova has built jinkō, a unique in silico clinical trial simulation platform to de-risk and accelerate clinical trials
À propos
Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations. Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials. Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed with Jinkō®.
- Site web
-
https://www.novainsilico.ai/contact-us/
Lien externe pour Nova In Silico
- Secteur
- Développement de logiciels
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Lyon, Rhône
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2010
- Domaines
- Pharmaceutical R&D, Computer Sciences, In silico clinical trials, Clinical pharmacology , QSP, PK/PD, Quantitative clinical pharmacology, Systems biology et Pharmacometrics
Produits
jinkō
Logiciel de simulation
Jinkō is the world’s first cloud-based modeling and clinical trial simulation platform 🖥 📈 With jinkō’s next-gen dynamic systems modeling platform, modelers and clinical trial teams can easily and collaboratively run trial simulations on hundreds or thousands of virtual patients in a matter of minutes to accelerate clinical development timelines and optimize trial design. ✅ Improves trial efficiencies ✅ Enables smaller sample sizes ✅ Is more ethical for patients ✅ Solves data and evidence gaps ✅ Vastly de-risks the drug decision process
Lieux
-
Principal
Obtenir l’itinéraire
1 Place Giovanni da Verrazzano
69009 Lyon, Rhône, FR
Employés chez Nova In Silico
Nouvelles
-
𝗧𝗵𝗲 𝗮𝗴𝗲𝗻𝘁 𝗱𝗶𝗱 𝗶𝘁! Well, not quite actually! Going agentic does 𝗻𝗼𝘁 mean working without human scientists’ expertise, let alone a visual, auditable interface. You can now steer your entire workflow through your favorite harness (Claude Code, Codex, Cursor, etc…) and orchestrate #Jinkō completely agentically with our open source plugins. Your agent can inspect and edit a model, configure a protocol, select or build a virtual population, launch a trial, retrieve results, and draft a report in Jinkō.✔️ That however does not mean you are losing control or scientific relevance. You still review the assumptions, check the outputs, and decide next steps, in jinkō, visually, same as before. Agents do scoped work; humans keep control. This is where #Jinkō’s interface comes in: complete auditability and centralized traceability for your teams. The practical value is speed. What we observe is that many clinical development questions are blocked not by a lack of modeling value, but by response time. We think agent-based workflows can help bring model-grounded answers closer to the timelines often needed for decision-making. We also think this is a significant opportunity for modeling teams broadly. Our current objective is to show that an important clinical development question can be answered substantially faster than a traditional workflow, without sacrificing scientific rigor, and produce capabilities the team can reuse. That's what we're working toward. More to come very soon! 🔜
-
Nous recrutons (#hiring) pour le poste de QSP Modeler (Lyon, Auvergne-Rhône-Alpes). Postulez dès maintenant ou partagez ce post avec votre réseau.
-
🚀 We're Hiring! Are you looking to join a dynamic team and contribute to impactful projects? We're looking for a QSP Modeler to join our team. ✨ What we offer: • Diverse and engaging projects • A collaborative and supportive team • An environment where you can grow and develop 👉 Learn more about the role and apply here: https://lnkd.in/dAz47Yc8 Feel free to share this post with your network! #Hiring #Pharma #Biotech #Pharmacometrics #QSP
-
Today, Jinkō is available in Claude Science. Claude Science is Anthropic's research partner for rigorous science. It runs analyses, searches databases, and traces every step of the work. Because it supports reusable skills, our open Jinkō skills and SDK plug straight in. That equips Claude Science with a causal, biology-grounded engine for in silico trials. Now, inside one workbench, claude can build a mechanistic model on Jinkō, generate a virtual population, design a protocol, run a trial, and bring back the results. Claude Science reasons and keeps the trail. Jinkō simulates cause and effect. One reasons. The other simulates the biology and provides instant feedback. Together they close the loop, with a scientist reviewing and owning every step. The Jinkō skills are open source. If you build with agents in R&D, you can try them today. https://www.jinko.ai/ https://lnkd.in/gbGcfC8a https://lnkd.in/eCQWVPqF https://lnkd.in/e5gq4sQ8 #agenticmidd
-
Our Nova in Silico Team, represented by Emmanuel P., is excited to join two key healthcare events tomorrow: ☀️ From 9:00 AM | AI 4 Clinical Trials Symposium by Future4care and Paris Saclay Cancer Cluster (PSCC) 👉Session #3 at 11:20 AM: "Clinical Trial conduct & Data analysis" 📍 The Hive (125 rue Edouard Vaillant, Villejuif) 🌙 From 5:00 PM | "Synthetic Control Arms and Clinical Trials: Building Tomorrow's Framework to Accelerate Access to Therapeutic Innovations" by ariis - Alliance Recherche Innovation Industries Santé, Sanofi and SILICA 👉 Round table discussion: "Fewer patients, more information: the promise of synthetic controls for better access to innovation?" led by Emmanuel P.. 📍 Future4Care (8 Rue Jean Antoine De Baïf, Paris) If you are attending those events, please don't hesitate to connect and have a chat! See you tomorrow! 🤝 #NovaInSilico #HealthcareInnovation #ClinicalTrials
-
-
Great to be at the #PAGE meeting this year! It’s been fantastic connecting with colleagues and engaging in such rich exchanges across the field. 🌍🤝 Events like this are the perfect opportunity to share how Nova In Silico’s tech-enabled services help accelerate drug development. The meeting isn't over yet! Stop by our booth to say hi and see our tech in action. Discover how a simple prompt with #kohai can generate a baseline QSP model of T2M diabetes in less than one minute ⏱️💡 Claudio Monteiro Samuel Laheux Théo G.
-
-
The booth is set and the team is ready in Dubrovnik! 🇭🇷 Claudio Monteiro, Théo G., and Samuel Laheux are officially ready for tomorrow at the Valamar Lacroma Hotel! 🚀 Here is what’s on the agenda at our booth: 💻 Live demonstrations of Jinkō, our AI-supercharged platform. 📊 Concrete use cases to show you how to optimize your clinical designs. 💡 Engaging discussions about the future of in silico modeling. Stop by and see us at Booth #24 and discover how Jinkō can empower you to tackle the complex drug development challenges of 2026. See you tomorrow! 👋 #PAGE2026 #Jinko #InSilico #ClinicalDesigns #DrugDevelopment #NovaInSilico
-
-
PAGE 2026 is just around the corner! 🗓️✨ Our Nova in Silico team is very excited to be attending this important event in Dubrovnik, Croatia, from June 2–5. 🇭🇷 Stop by Booth #24 to chat with our experts, see a live demo of Jinko—our AI-supercharged platform—and discover how we can tackle complex drug development challenges together! 🤖💊🔬 See you in Dubrovnik! 🌊🏰 #PAGE2026 #Jinko #InSilico #ClinicalDesigns #DrugDevelopment #NovaInSilico #PharmaTech
-
-
Join Nova at PAGE 2026! 🇭🇷 Our Nova in Silico team— Claudio Monteiro, Théo G. and Samuel Laheux —is excited to attend PAGE 2026 at the Valamar Lacroma Hotel in Dubrovnik, Croatia, from June 2 to June 5! Join us at Booth #24 to meet our experts, learn more about our service offerings, and discover Jinkō, our AI-supercharged platform. We will show you how Jinkō can empower you to tackle the complex drug development challenges in 2026 and optimize your clinical designs. 🗓️ On the agenda at our booth: 🔹Concrete use cases 🔹 Live demonstrations of the Jinkō platform Stop by and let's chat about the future of in silico modeling. See you in Dubrovnik! 🌊 #PAGE2026 #Jinko #InSilico #ClinicalDesigns #DrugDevelopment #NovaInSilico
-